Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Bladder Cancer
Interventions
OTHER

crystalloid

Group A (SVV \<10%): infuse crystalloid 6-10 ml/kg/hr during surgery. Group B (SVV 10-20%): infuse crystalloid 2-4 ml/kg/hr until cystectomy, 6-10 ml/kg/hr after cystectomy

OTHER

colloid

Group A (SVV \<10%): infuse colloid 200 ml if SVV is ≥ 10%. Group B (SVV 10-20%): infuse colloid 200 ml if SVV is \> 20%

OTHER

mannitol

Group B (SVV 10-20%): infuse mannitol 0.5 g/kg if SVV is \< 10%

OTHER

lasix

Group B (SVV 10-20%): infuse lasix 5 mg if SVV is \< 10%

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT02373735 - Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes | Biotech Hunter | Biotech Hunter